Agricultural Biotechnology Market Size, Share, Growth, and Industry Analysis, By Type (Molecular Diagnostics,Molecular Markers,Tissue Culture,Vaccines,Genetic Engineering,Others), By Application (Transgenic Crops,Synthetic Biology-Enabled Products,Others), Regional Insights and Forecast to 2035

Agricultural Biotechnology Market Overview

The global Agricultural Biotechnology Market size is projected to grow from USD 56094.09 million in 2026 to USD 61142.57 million in 2027, reaching USD 121830.38 million by 2035, expanding at a CAGR of 9% during the forecast period.

The Agricultural Biotechnology Market is experiencing significant growth, driven by advancements in genetic engineering, molecular diagnostics, and transgenic crop cultivation. In 2024, the total global transgenic crop area reached around 210 million hectares, with soybeans accounting for nearly 105 million hectares, maize at 68 million hectares, cotton at 25 million hectares, and canola at 10 million hectares. This wide adoption highlights the role of biotechnology in enhancing crop productivity and ensuring food security. By technology share, genetic engineering contributes approximately 25%, tissue culture holds nearly 20%, and molecular markers make up about 15% of the global market. Hybrid seeds account for around 30% of agricultural biotechnology products, while biofertilizers represent nearly 26%.

Plants dominate the biotechnology organism segment, holding about 61% share, while animals and microbes account for the remaining 39%. Applications are also concentrated in transgenic crops, representing about 56% of total agricultural biotechnology applications globally, followed by synthetic biology-enabled products and other niche uses. In terms of regional dominance, North America leads the market with over 40% share, followed by Asia-Pacific at approximately 28%, Europe at 20%, and the Middle East & Africa holding nearly 12%. These figures demonstrate strong global adoption and reliance on agricultural biotechnology solutions.

The USA Agricultural Biotechnology Market Analysis shows the country remains the largest adopter of genetically modified crops worldwide. In 2024, farmers planted nearly 91.5 million acres of corn, 86.1 million acres of soybeans, and 11.7 million acres of cotton. Among these, the adoption of biotech seeds was extremely high, with 94% of corn, 96% of soybean, and 96% of cotton acreage planted with genetically modified varieties. Herbicide-tolerant traits are particularly dominant, covering more than 95% of U.S. soybean acreage. In corn, insect-resistant Bt corn accounts for nearly 80% of total plantings, with stacked trait varieties representing 70% of the biotech corn area. Cotton follows similar patterns, where stacked herbicide-tolerant and insect-resistant traits represent more than 80% of biotech cotton acreage. The U.S. market also leads in biotechnology R&D spending, accounting for more than 45% of global agricultural biotech research expenditure. Investments focus heavily on CRISPR-based genome editing, drought-tolerant crop varieties, and biofertilizer innovations. This positions the U.S. agricultural biotechnology market as the backbone of global food security, contributing to high yields, reduced pesticide use by over 30%, and improved farm profitability across millions of acres.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: Adoption of genetically modified seeds increased by 62% globally in the last decade.
• Major Market Restraint: Regulatory hurdles affect nearly 40% of product approvals worldwide.
• Emerging Trends: CRISPR gene-editing accounts for 28% of recent biotech patents.
• Regional Leadership: North America controls 41% of global agricultural biotechnology share.
• Competitive Landscape: Top five companies hold 52% of the total global market share.
• Market Segmentation: Transgenic crops represent 56%, while synthetic biology products account for 18%.
• Recent Development: Investment in gene-edited crops rose by 35% between 2022–2024.

Agricultural Biotechnology Market Trends

The Agricultural Biotechnology Market Trends highlight multiple areas of innovation. The adoption of genetically modified seeds has expanded steadily, covering more than 210 million hectares globally by 2024. Farmers are increasingly shifting towards herbicide-tolerant and insect-resistant varieties, which represent more than 75% of biotech seed sales worldwide. Precision gene-editing technologies like CRISPR are now transforming the landscape. Approximately 28% of patents filed in agricultural biotechnology during 2023–2024 involved CRISPR or related editing tools. These innovations are enabling the development of drought-resistant maize, nitrogen-efficient rice, and disease-resistant bananas, directly addressing global challenges such as climate change and food insecurity.

The integration of biofertilizers and biopesticides is another strong trend. Biofertilizers now account for nearly 26% of biotechnology-related agricultural inputs, with usage increasing by more than 20% in the last five years. This shift reflects growing regulatory restrictions on synthetic agrochemicals and rising consumer demand for sustainable practices. Synthetic biology applications in agriculture are also on the rise. More than 18% of agricultural biotechnology market share is now linked to synthetic biology-enabled products, including engineered microbes designed to enhance soil fertility and improve crop health. Another emerging trend is digital biotechnology integration. More than 35% of large agricultural biotech firms are now combining genomics with AI-driven analytics to predict crop performance and reduce R&D timeframes by up to 40%.

Agricultural Biotechnology Market Dynamics

DRIVER

"Rising global demand for high-yield crops."

The world population exceeded 8 billion in 2023, pushing food demand up by nearly 35% compared with 2010. Biotechnology provides solutions such as drought-tolerant maize that can increase yields by 20% under water stress conditions and insect-resistant cotton that cuts pest losses by 30%. With global agricultural land remaining relatively constant, the ability to grow more food on the same acreage is a powerful driver for the Agricultural Biotechnology Market Growth.

RESTRAINT

"Stringent regulatory frameworks."

Nearly 40% of agricultural biotechnology product applications face regulatory delays exceeding three years in several regions. Europe, for example, has authorized fewer than 5% of submitted GM crop approvals in the past decade. These restrictions slow innovation, raise costs by over 25%, and create market fragmentation.

OPPORTUNITY

"Growth of biofertilizers and biopesticides."

Biofertilizers already represent 26% of agricultural biotechnology inputs and are expanding as governments restrict chemical fertilizer use. Biopesticides, covering 15% of crop protection solutions in 2024, are projected to increase sharply as demand for sustainable farming grows. These solutions cut greenhouse gas emissions by nearly 10% compared with conventional inputs, creating strong opportunities in the Agricultural Biotechnology Market Forecast period.

CHALLENGE

"Rising R&D costs and farmer adoption barriers."

Developing a new genetically engineered crop requires an investment of approximately $130–150 million and a timeline of 10–12 years. These costs pose challenges, especially for smaller firms. Additionally, while adoption rates exceed 90% in the U.S., they remain below 20% in several developing countries due to farmer concerns and lack of infrastructure.

Agricultural Biotechnology Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Molecular Diagnostics: Representing around 12% of total share, molecular diagnostics enable detection of plant diseases and pathogens. Nearly 45% of biotech farms in advanced economies use diagnostics to manage viral infections in crops.

The Molecular Diagnostics segment is projected to hold USD 9,856.7 million by 2025, growing to USD 21,390.4 million by 2034, at a 9.2% CAGR, accounting for 19% market share.

Top 5 Major Dominant Countries in Molecular Diagnostics Segment

• United States dominates with USD 3,250.8 million in 2025, reaching USD 7,250.1 million by 2034, holding 33% share at a 9.5% CAGR.
• China accounts for USD 2,125.4 million in 2025, projected to hit USD 4,900.6 million by 2034, with 22% share at a 9.3% CAGR.
• Germany stands at USD 1,350.7 million in 2025, expected to reach USD 3,100.5 million by 2034, capturing 14% share at a 9.0% CAGR.
• India contributes USD 980.3 million in 2025, projected to expand to USD 2,310.9 million by 2034, securing 10% share at a 9.1% CAGR.
• Brazil holds USD 850.5 million in 2025, expected to achieve USD 1,828.3 million by 2034, representing 8% share at a 9.2% CAGR.

Molecular Markers: Holding about 15% share, these tools accelerate crop breeding. Marker-assisted selection has reduced crop development time by 30% in maize and rice breeding programs.

The Molecular Markers segment is valued at USD 8,230.4 million in 2025, reaching USD 18,017.2 million by 2034, holding a 16% share at a 9.1% CAGR.

Top 5 Major Dominant Countries in Molecular Markers Segment

• United States leads with USD 2,520.1 million in 2025, projected to reach USD 5,610.8 million by 2034, holding 31% share at a 9.0% CAGR.
• China follows at USD 1,870.4 million in 2025, growing to USD 4,175.6 million by 2034, with 23% share at a 9.2% CAGR.
• Germany contributes USD 1,220.5 million in 2025, expected to hit USD 2,760.1 million by 2034, holding 15% share at a 9.1% CAGR.
• India accounts for USD 930.3 million in 2025, forecasted to reach USD 2,121.5 million by 2034, representing 11% share at a 9.3% CAGR.
• France holds USD 850.2 million in 2025, projected to achieve USD 1,890.3 million by 2034, capturing 10% share at a 9.0% CAGR.

Tissue Culture: Contributing nearly 20%, tissue culture methods are used for banana, sugarcane, and potato production. Over 2 billion tissue-cultured banana plantlets are produced annually.

The Tissue Culture segment is expected to reach USD 7,213.5 million in 2025 and expand to USD 15,908.4 million by 2034, with a 14% share at a 9.0% CAGR.

Top 5 Major Dominant Countries in Tissue Culture Segment

• United States leads with USD 2,050.7 million in 2025, projected to hit USD 4,580.1 million by 2034, securing 29% share at a 9.1% CAGR.
• China contributes USD 1,680.2 million in 2025, rising to USD 3,700.4 million by 2034, with 23% share at a 9.0% CAGR.
• India accounts for USD 1,020.6 million in 2025, reaching USD 2,210.3 million by 2034, holding 14% share at a 9.2% CAGR.
• Germany holds USD 925.4 million in 2025, projected to reach USD 2,050.2 million by 2034, representing 13% share at a 9.1% CAGR.
• Brazil secures USD 730.2 million in 2025, expected to achieve USD 1,368.1 million by 2034, with 10% share at a 9.0% CAGR.

Vaccines: Representing about 8%, biotech vaccines are used for livestock disease control. Around 60% of poultry farms in developed nations rely on biotech-derived vaccines.

The Agricultural Vaccines segment is valued at USD 6,180.4 million in 2025, forecasted to reach USD 13,609.3 million by 2034, capturing 12% share at a 9.0% CAGR.

Top 5 Major Dominant Countries in Vaccines Segment

• United States dominates with USD 1,890.3 million in 2025, expected to reach USD 4,110.8 million by 2034, securing 31% share at a 9.0% CAGR.
• China accounts for USD 1,420.5 million in 2025, projected to grow to USD 3,085.4 million by 2034, with 23% share at a 9.1% CAGR.
• India holds USD 960.4 million in 2025, reaching USD 2,130.2 million by 2034, capturing 15% share at a 9.0% CAGR.
• Germany contributes USD 830.5 million in 2025, projected to hit USD 1,850.7 million by 2034, with 12% share at a 9.1% CAGR.
• Brazil stands at USD 700.2 million in 2025, expanding to USD 1,433.3 million by 2034, holding 10% share at a 9.0% CAGR.

Genetic Engineering: The largest segment at 25%, focusing on GM seeds for corn, soybeans, and cotton. Over 95% of soybeans in the U.S. and 85% in Brazil use genetically engineered varieties.

The Genetic Engineering segment is projected at USD 15,985.2 million in 2025, rising to USD 35,172.3 million by 2034, representing 31% share at a 9.1% CAGR.

Top 5 Major Dominant Countries in Genetic Engineering Segment

• United States holds USD 5,152.3 million in 2025, reaching USD 11,378.1 million by 2034, securing 32% share at a 9.2% CAGR.
• China accounts for USD 4,050.8 million in 2025, expected to hit USD 8,910.2 million by 2034, capturing 25% share at a 9.0% CAGR.
• Brazil contributes USD 2,050.4 million in 2025, forecasted to reach USD 4,500.7 million by 2034, holding 13% share at a 9.0% CAGR.
• India secures USD 1,905.6 million in 2025, projected to grow to USD 4,187.4 million by 2034, representing 12% share at a 9.2% CAGR.
• Argentina accounts for USD 1,552.4 million in 2025, reaching USD 3,195.9 million by 2034, with 10% share at a 9.0% CAGR.

Others: Covering around 20%, including CRISPR-based products, biofertilizers, and microbial inoculants, which collectively reduce fertilizer use by 15%.

The Others segment is valued at USD 4,000.3 million in 2025, forecasted to reach USD 8,661.2 million by 2034, securing 8% share at a 9.0% CAGR.

Top 5 Major Dominant Countries in Others Segment

• United States dominates with USD 1,210.2 million in 2025, projected to reach USD 2,630.4 million by 2034, capturing 30% share at a 9.0% CAGR.
• China holds USD 1,000.5 million in 2025, expanding to USD 2,175.1 million by 2034, with 25% share at a 9.1% CAGR.
• India accounts for USD 800.6 million in 2025, expected to hit USD 1,704.3 million by 2034, with 20% share at a 9.2% CAGR.
• Germany contributes USD 600.4 million in 2025, reaching USD 1,278.3 million by 2034, representing 15% share at a 9.0% CAGR.
• Brazil secures USD 388.6 million in 2025, projected to hit USD 843.1 million by 2034, holding 10% share at a 9.0% CAGR.

BY APPLICATION

Transgenic Crops: Dominating with 56% of applications, transgenic crops improve yield by up to 25% and reduce pesticide use by nearly 30%.

The Transgenic Crops segment holds USD 24,702.4 million in 2025, projected to reach USD 54,281.2 million by 2034, securing 48% market share at a 9.1% CAGR.

Top 5 Major Dominant Countries in Transgenic Crops Application

• United States dominates with USD 8,150.6 million in 2025, projected to reach USD 18,100.4 million by 2034, with 33% share at a 9.2% CAGR.
• Brazil secures USD 5,200.3 million in 2025, expected to hit USD 11,700.9 million by 2034, representing 21% share at a 9.0% CAGR.
• China holds USD 4,750.7 million in 2025, growing to USD 10,510.5 million by 2034, capturing 19% share at a 9.2% CAGR.
• India contributes USD 3,920.8 million in 2025, projected to hit USD 8,560.2 million by 2034, with 16% share at a 9.1% CAGR.
• Argentina accounts for USD 2,680.4 million in 2025, reaching USD 5,409.2 million by 2034, holding 11% share at a 9.0% CAGR.

Synthetic Biology-Enabled Products: Accounting for 18%, engineered microbes enhance soil health. More than 40 million hectares globally are treated with such products.

The Synthetic Biology-Enabled Products segment is valued at USD 17,010.5 million in 2025, expanding to USD 36,682.1 million by 2034, securing 33% share at a 9.0% CAGR.

Top 5 Major Dominant Countries in Synthetic Biology-Enabled Products Application

• United States dominates with USD 6,020.6 million in 2025, projected to reach USD 12,890.4 million by 2034, representing 35% share at a 9.0% CAGR.
• China secures USD 4,230.4 million in 2025, expected to hit USD 9,160.5 million by 2034, capturing 25% share at a 9.2% CAGR.
• Germany holds USD 2,420.8 million in 2025, growing to USD 5,130.7 million by 2034, securing 14% share at a 9.1% CAGR.
• India contributes USD 2,150.2 million in 2025, projected to hit USD 4,580.1 million by 2034, with 12% share at a 9.0% CAGR.
• United Kingdom stands at USD 1,710.6 million in 2025, expanding to USD 3,320.4 million by 2034, holding 10% share at a 9.0% CAGR.

Others: Representing 26%, including vaccines, biopesticides, and biofuels. Biopesticide-treated acreage expanded by 15% in 2024.

The Others application segment is valued at USD 9,749.6 million in 2025, forecasted to reach USD 20,795.6 million by 2034, with 19% market share at a 9.0% CAGR.

Top 5 Major Dominant Countries in Others Application

• United States holds USD 3,020.4 million in 2025, reaching USD 6,430.3 million by 2034, capturing 31% share at a 9.0% CAGR.
• China accounts for USD 2,220.8 million in 2025, projected to hit USD 4,710.7 million by 2034, securing 23% share at a 9.1% CAGR.
• India contributes USD 1,890.5 million in 2025, expected to reach USD 3,980.4 million by 2034, representing 19% share at a 9.2% CAGR.
• Germany holds USD 1,370.7 million in 2025, projected to hit USD 2,870.2 million by 2034, with 14% share at a 9.0% CAGR.
• France secures USD 1,247.2 million in 2025, growing to USD 2,424.0 million by 2034, holding 13% share at a 9.0% CAGR.

Agricultural Biotechnology Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

dominates the Agricultural Biotechnology Market Share, with about 41% of global adoption. The U.S. accounts for the majority, with nearly 94% of corn, 96% of soybean, and 96% of cotton acreage planted with biotech varieties. Canada also contributes significantly, with biotech canola covering over 90% of national acreage.

The North America Agricultural Biotechnology Market is projected to reach USD 18,951.2 million in 2025 and expand to USD 40,281.5 million by 2034, holding 36% global share at a 9.1% CAGR.

North America - Major Dominant Countries in the Agricultural Biotechnology Market

• United States leads with USD 13,580.5 million in 2025, expected to reach USD 29,012.6 million by 2034, holding 71% regional share at a 9.2% CAGR.
• Canada secures USD 2,770.3 million in 2025, projected to hit USD 5,891.4 million by 2034, representing 15% share at a 9.0% CAGR.
• Mexico contributes USD 1,680.4 million in 2025, forecasted to grow to USD 3,601.7 million by 2034, with 9% share at a 9.1% CAGR.
• Cuba accounts for USD 540.2 million in 2025, expected to expand to USD 1,120.3 million by 2034, capturing 3% share at a 9.0% CAGR.
• Costa Rica holds USD 380.1 million in 2025, projected to hit USD 656.4 million by 2034, securing 2% share at a 9.1% CAGR.

EUROPE

holds about 20% of the global market. Spain and Portugal lead in GM maize cultivation, covering 25% of EU biotech crop acreage. However, strict regulations have limited broader adoption. Still, molecular markers and tissue culture technologies are widespread in plant breeding programs, accounting for 35% of biotech applications in Europe.

The Europe Agricultural Biotechnology Market is valued at USD 13,840.4 million in 2025, forecasted to expand to USD 30,020.7 million by 2034, securing 27% global share at a 9.0% CAGR.

Europe - Major Dominant Countries in the Agricultural Biotechnology Market

• Germany dominates with USD 4,010.5 million in 2025, projected to reach USD 8,730.2 million by 2034, holding 29% regional share at a 9.1% CAGR.
• France secures USD 3,010.7 million in 2025, growing to USD 6,510.8 million by 2034, representing 22% share at a 9.0% CAGR.
• United Kingdom contributes USD 2,510.2 million in 2025, expected to expand to USD 5,420.6 million by 2034, with 18% share at a 9.0% CAGR.
• Italy accounts for USD 2,010.3 million in 2025, projected to hit USD 4,250.1 million by 2034, securing 15% share at a 9.1% CAGR.
• Spain holds USD 1,500.6 million in 2025, forecasted to achieve USD 3,109.0 million by 2034, with 11% share at a 9.0% CAGR.

ASIA-PACIFIC

accounts for 28% of global market share. China planted over 6 million hectares of GM cotton, representing 95% of national cotton acreage. India grew about 11 million hectares of Bt cotton, covering over 90% of total cotton area. The Philippines and Vietnam have adopted biotech maize across more than 3 million hectares combined.

The Europe Agricultural Biotechnology Market is valued at USD 13,840.4 million in 2025, forecasted to expand to USD 30,020.7 million by 2034, securing 27% global share at a 9.0% CAGR.

Europe - Major Dominant Countries in the Agricultural Biotechnology Market

• Germany dominates with USD 4,010.5 million in 2025, projected to reach USD 8,730.2 million by 2034, holding 29% regional share at a 9.1% CAGR.
• France secures USD 3,010.7 million in 2025, growing to USD 6,510.8 million by 2034, representing 22% share at a 9.0% CAGR.
• United Kingdom contributes USD 2,510.2 million in 2025, expected to expand to USD 5,420.6 million by 2034, with 18% share at a 9.0% CAGR.
• Italy accounts for USD 2,010.3 million in 2025, projected to hit USD 4,250.1 million by 2034, securing 15% share at a 9.1% CAGR.
• Spain holds USD 1,500.6 million in 2025, forecasted to achieve USD 3,109.0 million by 2034, with 11% share at a 9.0% CAGR.

MIDDLE EAST & AFRICA

This region represents about 11% of the market. South Africa leads with over 2.7 million hectares of GM maize, soybeans, and cotton. Sudan has adopted Bt cotton across more than 300,000 hectares, representing 95% of cotton acreage. Nigeria approved biotech cowpea, which reached over 100,000 hectares by 2024.

The Middle East & Africa Agricultural Biotechnology Market is expected to reach USD 3,770.6 million in 2025, expanding to USD 7,956.0 million by 2034, holding 8% global share at a 9.0% CAGR.

Middle East and Africa - Major Dominant Countries in the Agricultural Biotechnology Market

• South Africa leads with USD 1,250.2 million in 2025, forecasted to reach USD 2,630.4 million by 2034, securing 33% regional share at a 9.0% CAGR.
• Saudi Arabia secures USD 870.3 million in 2025, projected to hit USD 1,850.7 million by 2034, capturing 23% share at a 9.1% CAGR.
• United Arab Emirates contributes USD 720.1 million in 2025, expected to grow to USD 1,520.4 million by 2034, with 19% share at a 9.0% CAGR.
• Egypt holds USD 560.4 million in 2025, expanding to USD 1,159.7 million by 2034, representing 15% share at a 9.0% CAGR.
• Nigeria accounts for USD 370.2 million in 2025, projected to reach USD 795.1 million by 2034, securing 10% share at a 9.1% CAGR.

List of Top Agricultural Biotechnology Companies

• DuPont Pioneer Hi-Bred
• KWS SAAT
• Mycogen Seeds.
• Dow AgroSciences
• Syngenta
• Vilmorin
• Bayer CropScience
• Certis
• Monsanto
• Evogene

Bayer AG: through its Crop Science division, remains the global frontrunner in biotechnology-driven agriculture, offering a wide portfolio of genetically modified seeds including herbicide-tolerant soybeans, insect-resistant corn, and biotech cotton

Corteva Agriscience: is the second-largest player, with significant strength in hybrid seeds, transgenic crop traits, and biological solutions

Investment Analysis and Opportunities

Investments in the Agricultural Biotechnology Market have accelerated, with more than $15 billion globally directed toward R&D between 2020 and 2024. Approximately 35% of these investments were focused on genetic engineering, while 25% targeted CRISPR and genome-editing technologies. Synthetic biology attracted nearly 20%, reflecting rising demand for engineered microbes. Private equity and venture capital investments increased significantly. Over 120 start-ups in biotech agriculture received funding between 2022 and 2024, particularly in areas of biofertilizers, biopesticides, and precision gene-editing.

Opportunities are strongest in Asia-Pacific and Africa, where rising food demand will require a 35% increase in crop output by 2030. Governments in India, China, and Nigeria are offering subsidies covering 20–30% of biotech seed costs. Sustainability-driven opportunities are also expanding. Biofertilizer adoption could reduce synthetic fertilizer usage by 15%, cutting greenhouse gas emissions by nearly 10%. Similarly, biopesticides are expected to expand acreage coverage by 20 million hectares by 2030. The Agricultural Biotechnology Market Outlook suggests continued investment growth, with strong opportunities in genome editing, climate-resilient crops, and biologically based inputs.

New Product Development

Innovation in the Agricultural Biotechnology Industry Report highlights continuous product development. In 2024, more than 60 new biotech crop varieties were commercialized globally. These included drought-tolerant maize capable of producing 20% higher yields under water stress and virus-resistant cassava adopted across 500,000 hectares in Africa. CRISPR-based genome editing accelerated product launches. Approximately 28% of new biotech seeds released in 2024 were developed using CRISPR methods, cutting development time by nearly 40%. Biofertilizer innovations also expanded, with more than 15 new microbial inoculants introduced in 2023–2024. These products increased nitrogen uptake by 25% in wheat and maize trials.

Livestock biotechnology is also advancing, with vaccines targeting African swine fever and avian influenza. More than 10 new biotech vaccines were approved in 2024, protecting livestock across 30 countries. Synthetic biology is enabling engineered microbes that protect against soil pathogens. At least 12 new microbial solutions reached the market in 2023–2024, covering crops such as rice, soybeans, and wheat. The Agricultural Biotechnology Market Growth is now strongly influenced by new product pipelines, with over 200 biotech traits under regulatory review globally.

Five Recent Developments

• Launch of drought-tolerant maize in Africa covering 1.2 million hectares in 2024.
• Introduction of CRISPR-edited rice varieties in Asia, improving yield by 18%.
• Approval of biotech cowpea in Nigeria, reaching 100,000 hectares adoption in 2024.
• Expansion of biofertilizer use in India, covering 8 million hectares of farmland.
• Commercialization of virus-resistant cassava, reducing yield losses by 30% across African nations.

Report Coverage of Agricultural Biotechnology Market

The Agricultural Biotechnology Market Research Report provides comprehensive coverage across technologies, applications, and regions. It examines adoption trends across more than 210 million hectares of biotech crops and analyzes product pipelines including over 200 traits under regulatory review. Technology segments include genetic engineering (25%), tissue culture (20%), molecular diagnostics (12%), molecular markers (15%), vaccines (8%), and others (20%). Application coverage spans transgenic crops (56%), synthetic biology-enabled products (18%), and other biotech uses (26%). Regional insights cover North America (41% share), Asia-Pacific (28%), Europe (20%), and Middle East & Africa (11%).

Crop-level adoption includes 105 million hectares of soybeans, 68 million hectares of maize, 25 million hectares of cotton, and 10 million hectares of canola. The report also covers competitive dynamics. The top five companies hold 52% market share, with Monsanto (18%) and Bayer CropScience (16%) leading. Future Agricultural Biotechnology Market Opportunities are highlighted in genome editing, biofertilizers, and biopesticides, which are expected to reduce chemical inputs by 15–20% globally. The scope of this Agricultural Biotechnology Industry Analysis ensures detailed insights into market size, market trends, market share, and strategic developments across the industry.

Agricultural Biotechnology Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 56094.09 Million in 2026
Market Size Value By	USD 121830.38 Million by 2035
Growth Rate	CAGR of 9% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Molecular Diagnostics Molecular Markers Tissue Culture Vaccines Genetic Engineering Others By Application : Transgenic Crops Synthetic Biology-Enabled Products Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample